Benostan

CDMO

Greece

https://www.benostan.com/

Is this your company? Claim this profile

Drug Product

Company Overview

About

Benostan is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Quality Control, Stability Testing, Method Development

Therapeutic Areas

Cardiovascular

Endocrinology

Quick Facts

HQ:Greece

Founded:2014

Employees:1,308

Capabilities & Services

Core Capabilities

Sterile Injectable
Sterile Fill/Finish
Fill/Finish (Vials)

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Cartridge / Pen

Containment Capabilities

OEB 4 (1-10 µg/m³)

Production Scales

Phase II

Clinical

Pilot Scale

Markets Served

Global

Regulatory Approvals

Drug Approval LV8ET8

EMA · #APR-UAIP9F7J · 2020-12-01

Drug Approval 328XB1

FDA · #APR-B20622VP · 2018-05-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-V7KPXDUI

Issued: 2020-04-09

Expires: 2025-04-25

ISO 13485:2016

International Organization for Standardization

Cert #: CERT-J4PU51HL

Issued: 2020-06-05

Expires: 2025-08-28

Health Canada GMP

Health Canada

Cert #: CERT-E2BLATEE

Issued: 2020-03-06

Expires: 2025-04-20

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Benostan

Benostan is headquartered in Greece.
Benostan was founded in 2014.
Benostan has 1,308 employees.
Benostan's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).

Find CDMOs like Benostan

Directory pages this company appears in, each with the full list of matching manufacturers.

Sterile Injectable CDMOs Fill-Finish CDMOs Fill/Finish (Vials) CDMOs Cartridge / Pen CDMOs OEB 4 (1-10 µg/m³) CDMOs